Wall Street secured gains again by late afternoon Wednesday in unpredictable trading following President-elect Donald Trump's first press conference since July. The Volatility Index, otherwise known as the fear index, spiked earlier in the session. Biotech companies and drugmakers were broadly lower after Trump suggested he would aggressively negotiate the price the U.S. pays for drugs. Stocks including Allergan (AGN) , Mylan (MYL) , Perrigo (PRGO) , Valeant (VRX) and Bristol-Myers Squibb (BMY) slumped after Trump's late-morning presser. Workday (WDAY) climbed after Walmart (WMT) signed up for a subscription, a deal that will likely cover the highest number of workers in the company's history. The world's largest retailer has more than two million employees worldwide. Volkswagen (VLKAY) rose after securing a plea deal with U.S. regulators worth $4.3 billion. The case covered the automaker's highly-publicized emissions-rigging scandal.
More from Video
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment
Citi overcame a mixed print to send its stock surging on Monday.
Real Money Video Wrap: Apple Rallies as Services Segment Takes Center Stage
There is a lot of Apple news to chew on Wednesday.
Are Algos Jumping on J&J Headlines?
Are machines jumping on Johnson & Johnson's human risk headlines?
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.